SCHEMBL7196

SCHEMBL7196

Cc1noc(-c2ccc(Br)cc2)c1[C@@H](CO)[S+]([O-])Cc1ccccc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.34
RAB9A P51151 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
LMNA P02545 1/20 0.34
LPAR1 Q92633 4/20 0.34
BRD4 O60885 7/20 0.32
LPAR3 Q9UBY5 2/20 0.32
ALDH1A1 P00352 2/20 0.32
MAPT P10636 1/20 0.32
LPAR2 Q9HBW0 1/20 0.32
NR1H4 Q96RI1 1/20 0.32
GAA P10253 1/20 0.32
TRPV1 Q8NER1 1/20 0.31
NPC1 O15118 1/20 0.31
BRD2 P25440 3/20 0.31
BRD3 Q15059 2/20 0.31
ABCC3 O15438 1/20 0.31
ABCC4 O15439 1/20 0.31
ABCB11 O95342 1/20 0.31
CYP2C8 P10632 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7195 0.82 BRD4 (0.34) SMN1; SMN2RAB9AL3MBTL1LMNALPAR1
SCHEMBL7194 0.82 BRD4 (0.34) SMN1; SMN2RAB9AL3MBTL1LMNALPAR1
SCHEMBL6830 0.81 RAB9A (0.34) SMN1; SMN2RAB9AL3MBTL1LMNALPAR1
SCHEMBL6734 0.76 ADRB2 (0.38) SMN1; SMN2RAB9AL3MBTL1LMNALPAR1
SCHEMBL1925 0.76 LPAR1 (0.36) SMN1; SMN2RAB9AL3MBTL1LMNALPAR1
SCHEMBL6943 0.76 EPHX1 (0.35) SMN1; SMN2RAB9AL3MBTL1LMNALPAR1
SCHEMBL1909 0.76 LPAR1 (0.36) SMN1; SMN2RAB9AL3MBTL1LMNALPAR1
SCHEMBL2087 0.76 EPHX1 (0.35) SMN1; SMN2RAB9AL3MBTL1LMNALPAR1
SCHEMBL1060 0.75 LPAR1 (0.35) SMN1; SMN2RAB9AL3MBTL1LMNALPAR1
SCHEMBL6836 0.75 ALDH1A1 (0.38) SMN1; SMN2RAB9AL3MBTL1LMNALPAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483252-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
WO-2011041694-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed